As of 2025-07-12, the Relative Valuation of KemPharm Inc (KMPH) is (23.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.81 USD, the upside of KemPharm Inc based on Relative Valuation is -499.9%.
The range of the Relative Valuation is (23.28) - (22.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 18.4x | 18.0x |
| Forward P/E multiples | 19.3x - 22.2x | 20.6x |
| Fair Price | (23.28) - (22.20) | (23.24) |
| Upside | -500.8% - -482.1% | -499.9% |
| Date | P/E |